Program Description Due to the rising prevalence and significant burden of Alzheimer?s disease there is a critical need for continuing education aimed at bridging existing gaps in clinician knowledge, competence, and performance concerning novel and emerging amyloid-targeting therapies (ATTs), espec
CME Credit: 1.00Program Description Recently, interleukin (IL)-23 and the inflammatory IL-23/T-helper (Th)-17 axis have been identified as central drivers of inflammation related to inflammatory bowel disease (IBD). Science in the field of cytokine-targeting therapies, specifically in the field of IL-23 P19 targeti
CME Credit: 1.50Program Description Reducing barriers to adequate anticoagulation for patients with cancer improves outcomes for those with cancer-associated venous thromboembolisms (CA-VTEs). Advances in cancer treatments and the resulting improvements in patient survival have led to an increase in the number of p
CME Credit: 1.00This program is designed to educate providers that treat patients with CRSwNP to identify symptoms and provide accurate diagnosis; select appropriate treatment regimens based on guideline recommendations; be aware of the latest evidence on novel treatment options; and have a patient-centric lens tha
CME Credit: 0.50Program Description Dr. Timothy Henry will discuss antiplatelet concerns and pharmacodynamics in the context of cardiogenic shock. Dr. Jennifer Rymer will review trial data, indications, and contradictions on cangrelor. This will be followed by Dr. Greg Serrao discussing antiplatelet concerns and in
CME Credit: 0.75Program Description Join Dr. Genevieve Neil-Perry as she moderates a dynamic panel discussion on the obstacles hindering access to quality menopause treatment. Dr. Gregg Sherman (primary care) and Dr. Nanette Santoro (OB/GYN) bring their clinical perspectives, while a patient joins and shares their
CME Credit: 0.25Agenda Part 1: Overview of mCRPC in 2024 Part 2: Precision Oncology = Better Outcomes Part 3: Translating Genetic Testing Results into Treatment Decisions Part 4: Sequencing Considerations and Optimizing Therapy for mCRPC Program Description This educational programming is divided into 4 microlearni
CME Credit: 1.00This educational activity is divided into chapter-based video dramas from the perspectives of physicians and their patients. It is designed to improve the ability of primary care providers, including primary care physicians and other members of the multidisciplinary team to diagnose and manage patie
CME Credit: 0.50Every 5 minutes, someone is diagnosed with MS, according to the Multiple Sclerosis International Federation?s Atlas of MS. Along with 85% of other newly diagnosed patients with MS, they will be diagnosed with relapsing-remitting MS (RRMS), one of the four MS subtypes. In 2024, five emerging Bruton?s
CME Credit:Program Description This interactive infographic covers a variety of topics surrounding the role of insulin therapy in type 2 diabetes (T2D) management, including practical pearls for initiation and maintenance of insulin therapy, how insulin therapy fits in with other T2D treatment options, and eme
CME Credit: 1.50